Search

Displaying results 6321 - 6330 of 8696 in total
  1. Drug

    Apatorsen

    go.drugbank.com/drugs/DB06094
    Investigational

    Apatorsen is a second generation antisense drug which in preclinical experiments, inhibits production of Heat Shock Protein 27 (Hsp27) a cell survival protein found at elevated levels in many human cancers

  2. Drug

    Tandutinib

    go.drugbank.com/drugs/DB05465
    Investigational

    MLN518 is a novel, oral, small molecule designed to inhibit type III receptor tyrosine kinases, including FLT3, (platelet-derived growth-factor receptor) PDGFR and c-KIT.

  3. Drug

    Esflurbiprofen

    go.drugbank.com/drugs/DB16159
    Investigational

    Esflurbiprofen is under investigation in clinical trial NCT03434197 (Safety and Efficacy of SFPP in Knee Osteoarthritis).

    Categories: Topical Products for Joint and Muscular Pain, Antiinflammatory Preparations, Non-Steroids for Topical Use
  4. Drug

    Heparan-N-sulfatase (human, recombinant)

    go.drugbank.com/drugs/DB18483
    Investigational

    Recombinant human heparan-N-sulfatase (rhHNS) is under investigation for the treatment mucopolysaccharidosis type IIIA.

  5. Drug

    Fluocortin

    go.drugbank.com/drugs/DB13223
    Experimental

    Fluocortin has been studied as a corticosteroid for treatment of dermatitis and eczema Spain [A174817].

  6. Drug

    Ulinastatin

    go.drugbank.com/drugs/DB12038
    Investigational

    Ulinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to Drug.

  7. Drug

    Atopaxar

    go.drugbank.com/drugs/DB12046
    Investigational

    Atopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome.

  8. Drug

    AZD-7762

    go.drugbank.com/drugs/DB12242
    Investigational

    AZD7762 has been investigated for the treatment of Cancer, Solid Tumors, and Advanced Solid Malignancies.

  9. Drug

    Utomilumab

    go.drugbank.com/drugs/DB15113
    Investigational

    Utomilumab is under investigation in clinical trial NCT03318900 (T Cell Immunotherapy for Advanced Ovarian Cancer).

  10. Drug

    Dapivirine

    go.drugbank.com/drugs/DB08639
    Investigational

    Dapivirine has been investigated for the prevention of HIV-1 Infections and Topical Penile Exposures.